Open AccessMaternal Neutralizing Antibody and Transmission of Hepatitis C Virus to Infants
Author(s) -
Kimberly A. Dowd,
Ronald C. Hershow,
Sigal Yawetz,
Philip LaRussa,
Clemente Díaz,
Sheldon H. Landesman,
Mary E. Paul,
Jennifer S. Read,
Mingjian Lu,
David L. Thomas,
Dale Netski,
Stuart C. Ray
Publication year - 2008
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/593067
Subject(s) - virology , hepatitis c virus , coinfection , neutralizing antibody , medicine , antibody , transmission (telecommunications) , titer , flaviviridae , virus , immunology , hepatitis c , heterologous , biology , electrical engineering , engineering , biochemistry , gene
To determine whether lower levels of hepatitis C virus (HCV)-specific neutralizing antibodies (nAb) are associated with an increased risk of mother-to-child transmission (MTCT) of HCV, HCV nAb titers were assessed in 63 mothers coinfected with HCV and human immunodeficiency virus (HIV) type 1. Of the mothers, 16 transmitted HCV to their infant, but no difference was detected between the ability of maternal plasma from transmitters and nontransmitters to neutralize heterologous HCV pseudoparticles (median nAb titer, 1:125 vs. 1:100; P = .23). In the setting of HIV/HCV coinfection, we found no evidence that HCV nAbs are associated with the prevention of MTCT of HCV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom